- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/12 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
Patent holdings for IPC class C07D 498/12
Total number of patents in this class: 76
10-year publication summary
|
3
|
2
|
5
|
4
|
5
|
4
|
6
|
10
|
6
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| S*BIO Pte Ltd. | 28 |
4 |
| F. Hoffmann-La Roche AG | 7961 |
3 |
| Salix Pharmaceuticals, Ltd. | 47 |
3 |
| Hoffmann-La Roche Inc. | 3303 |
2 |
| The Regents of the University of Michigan | 4596 |
2 |
| Actelion Pharmaceuticals Ltd | 554 |
2 |
| AREVIPHARMA GmbH | 6 |
2 |
| Azad Pharma AG | 23 |
2 |
| CTI Biopharma Corp. | 39 |
2 |
| Indena S.p.A. | 654 |
2 |
| Katholieke Universiteit Leuven | 1116 |
2 |
| Revolution Medicines, Inc. | 207 |
2 |
| Salix Pharmaceuticals, Inc. | 91 |
2 |
| Tiumbio Co., Ltd. | 23 |
2 |
| Innovstone Therapeutics Limited | 13 |
2 |
| Fochon Biosciences, Ltd. | 28 |
2 |
| Bristol-myers Squibb Company | 4877 |
1 |
| Samsung Display Co., Ltd. | 33072 |
1 |
| Genentech, Inc. | 3886 |
1 |
| Merck Sharp & Dohme Corp. | 2214 |
1 |
| Other owners | 36 |